Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models. - Wikidata - wikimedia - TriplyDB

Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models.

Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models.

http://www.wikidata.org/entity/Q33995614

about

Genetic Engineering of Mesenchymal Stem Cells to Induce Their Migration and Survival Neural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challenges Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies Developing stem cell therapies for juvenile and adult-onset Huntington's disease Mesenchymal stem cells for the treatment of neurodegenerative and psychiatric disorders Mouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.Dynamic Imaging of Marrow-Resident Granulocytes Interacting with Human Mesenchymal Stem Cells upon Systemic Lipopolysaccharide Challenge.Preclinical efficacy and mechanisms of mesenchymal stem cells in animal models of autoimmune diseases.The stem cell secretome and its role in brain repair.Use of Genetically Altered Stem Cells for the Treatment of Huntington's Disease.Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model.Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6/2 transgenic mouse model of Huntington's disease Intrastriatal transplantation of neurotrophic factor-secreting human mesenchymal stem cells improves motor function and extends survival in R6/2 transgenic mouse model for Huntington's disease.Stem cell therapy in neurodegenerative diseases: From principles to practice.Bone Marrow-Derived Mesenchymal Stem Cells Repair Necrotic Pancreatic Tissue and Promote Angiogenesis by Secreting Cellular Growth Factors Involved in the SDF-1 α /CXCR4 Axis in Rats Disruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell models of Huntington's disease.Testing stem cell therapy in a rat model of inflammatory bowel disease: role of bone marrow stem cells and stem cell factor in mucosal regeneration Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington's disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number.Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis.Mesenchymal stem cell-based therapy.Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice.Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation.Stem cell-based therapy for Huntington's disease.Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play.Mesenchymal Stem Cells Stabilize Axonal Transports for Autophagic Clearance of α-Synuclein in Parkinsonian Models.Umbilical cord: an unlimited source of cells differentiable towards dopaminergic neurons Stem cell models of polyglutamine diseases and their use in cell-based therapies.Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes.Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.Xenotransplantation of human adipose derived mesenchymal stem cells in a rodent model of Huntington's disease: motor and non-motor outcomes.Single-cell suspension methodology favors survival and vascularization of fetal striatal grafts in the YAC128 mouse model of Huntington's disease.Concise Review: The Use of Stem Cells for Understanding and Treating Huntington's Disease.Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's Disease.Treatment of Spinocerebellar Ataxia With Mesenchymal Stem Cells: A Phase I/IIa Clinical Study.Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases.Effects of Passage Number and Differentiation Protocol on the Generation of Dopaminergic Neurons from Rat Bone Marrow-Derived Mesenchymal Stem Cells.Defined serum- and xeno-free cryopreservation of mesenchymal stem cells Bone Marrow Derived Mesenchymal Stem Cells in Addiction Related Hippocampal Damages

P2860

Q26744561-B03B44AA-93A0-40B6-91DC-DA83528D1A0D Q26775932-4BB76EAA-34C8-49B6-A93F-538EAD669EFF Q26799107-68C61F29-3106-420B-8077-7EE26790FD04 Q26799722-634AA2C0-CFAA-487A-A49B-FFFFCE65FAF8 Q26801575-12E4265D-968C-4F81-A250-3C3BFDD9CC17 Q27005950-C98EAE7F-7918-43A7-A332-424E5CF6F73E Q30538835-D8C8A66F-01E9-4887-9A50-FE6B7D4A026D Q33619017-37F5BA92-B53E-4AFB-8132-9767C3A1FC0C Q33771698-C6794FC9-B763-4B8D-8573-4C89FFE1AE68 Q33788929-322145D3-C04E-4E5C-9659-37CDCE5ECA10 Q33939904-DC2C597C-C5C4-4CB0-B8AF-C5134FFD23CD Q34372919-ADCBB306-6158-4DF1-BD92-13F57DE50985 Q34406937-ED49C84D-C7C9-4B09-AA7E-64EB8F3CBF07 Q34997944-7522E49B-0435-489C-A947-3883B59F169D Q35166316-98CE8855-153A-47F7-AC81-42A706C8A69B Q35239346-870B65BC-5202-4123-B76D-F1B482D6386E Q35326009-D49BFB14-DB42-4EA4-87DA-08E1A9F9127A Q35600187-706E6CFB-724A-49B4-BF49-2FA0080B4CDB Q35675598-60D36CD6-7FA5-4DBA-80B8-5F377385A81F Q36419634-FC5F8852-D85B-42AD-9CDA-B92A2CC66D91 Q36546424-CC1FEF26-D3BA-4A50-BC34-F37BFA2E2AA9 Q37050899-C9CB3C87-35A9-4366-A28C-9579DE5CC90A Q38043528-5934F017-2655-4F3D-B334-1EC142551387 Q38055455-7F623CA2-08F2-444C-A0EE-3551355C0465 Q38088965-67C8FF1F-101F-41F1-AC0B-A8CED72CAD4C Q38744332-1021D3C8-47C3-4095-ACB2-D7CC6FFEE2CD Q41429938-B7E754B7-CA41-4B0D-A1A2-C097B3783D20 Q41472176-548A69F0-0A96-461E-A189-CC0922965A84 Q42392488-D21C1D7D-B54A-4C2B-9BFF-E541993A4CC6 Q42593149-481A7CFD-80D7-4685-9671-CB4D0AE6FA77 Q42692081-368B525F-8F45-42D7-A586-0C2964B544A6 Q45293677-B97ED690-D176-4C86-97A4-54D892343EBE Q45305684-9A64BA53-8F22-4F4C-8856-D3E1E5646471 Q45305883-C85B70E2-FC40-474C-998F-F322DC3AED08 Q45619589-76BC72BB-CA51-4187-B82D-D505C3F9D045 Q47941437-D4C2DFAD-7081-440C-967B-980AC443C630 Q54967971-26A70BC4-1156-40E3-BCA0-BD76C70805CD Q57094520-62DE6D99-85B4-4F3F-B369-4D8608DF03A3 Q57146788-13D2FA4B-0FEE-4864-91F8-C316A6F31270

P2860

Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models.

http://www.wikidata.org/entity/Q33995614

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Human mesenchymal stem cells p ...... ington's disease mouse models.

@ast

Human mesenchymal stem cells p ...... ington's disease mouse models.

@en

type

label

Human mesenchymal stem cells p ...... ington's disease mouse models.

@ast

Human mesenchymal stem cells p ...... ington's disease mouse models.

@en

prefLabel

Human mesenchymal stem cells p ...... ington's disease mouse models.

@ast

Human mesenchymal stem cells p ...... ington's disease mouse models.

@en

P1433

Q33995614-0B56E66A-5E16-4364-8D55-08515EC6DA5F

P1476

Q33995614-32EDE307-05C8-4192-B7DD-4C3D878F5695

P2093

Q33995614-35FBCB50-E760-4E84-BCB4-75C8EEF1A0C3

Q33995614-6F9CAE47-A2FF-4E6A-A298-BC8CFF1B8952

Q33995614-C277E9DF-E2A6-4564-A981-21CECAEF30F8

Q33995614-D0862124-B902-4D9A-84CB-D872C01E48D3

Q33995614-DA576BD3-8FC6-4687-84EB-B6856484F202

Q33995614-DB3C1963-336E-4905-A9BB-E34737D3AD6F

Q33995614-DCB1071E-EA57-47E2-9769-3D8FBF791E94

P2860

Q33995614-04429A8D-4D58-409D-B3BE-0BE54F3BDC4E

Q33995614-068D98D9-3F28-4629-8B29-228D76A4993B

Q33995614-072CEF1D-0BFD-4310-B1C5-B062BBC956FB

Q33995614-093F9367-C5C9-4C43-A837-0440B6833465

Q33995614-09CB000E-3CD0-4DD6-B331-64DECE7A9CC4

Q33995614-11B6882E-000B-41DF-933A-4C7BDEFFB956

Q33995614-146106F5-3B18-4B6F-82D9-B3E487BC4423

Q33995614-14E7E6A5-D2B3-4FEF-9668-DE2B307624D7

Q33995614-1687DDEE-7D86-4EEF-B780-EBC933E8026C

Q33995614-16A5DCCD-F22E-48B5-9F99-7E811CAC8E27

P304

Q33995614-BEFBF3CC-EA5B-477F-8A5B-EC2B99062907

P31

Q33995614-D98D239F-A16A-4AA9-AF46-6AECA0670A9A

P356

Q33995614-5245BCCE-8FF3-4D33-8959-E26AE9FCAB1A

P407

Q33995614-5C538C3B-6815-44AC-BDAB-23B3406459CA

P433

Q33995614-E435B2C4-BC82-46CC-96B8-6BF856B15A5A

P478

Q33995614-11E50470-E3CC-4984-BEA7-D91E1E2F76F1

P50

Q33995614-67E58605-620B-47DC-BA3E-C29B74AFBC7E

P577

Q33995614-AAE6E56C-31EC-46ED-90A6-657230D907BC

P5875

Q33995614-BF3C97A0-53CA-4C6C-BC51-367F6DA4AA37

P698

Q33995614-821D17A7-E4A2-40EF-A76E-95825A63C580

P921

Q33995614-AF0ED06B-5151-4C60-BFDA-D24D6B1902F2

P932

Q33995614-B51C3AEA-335F-45AB-AA29-19DD1777FDEB

P356

JOURNAL.PONE.0022924

P1433

P1476

Human mesenchymal stem cells p ...... tington's disease mouse models

@en

P2093

Che-Kun James Shen

http://www.w3.org/2001/XMLSchema#string

Hsin-Lan Wen

http://www.w3.org/2001/XMLSchema#string

Hsiu Mei Hsieh-Li

http://www.w3.org/2001/XMLSchema#string

Hung Li

http://www.w3.org/2001/XMLSchema#string

Tzu-Hao Cheng

http://www.w3.org/2001/XMLSchema#string

Ya-Chin Chang

http://www.w3.org/2001/XMLSchema#string

Yuan-Ta Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice.

Multilineage potential of adult human mesenchymal stem cells

Neuronal replacement from endogenous precursors in the adult brain after stroke

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.

Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats.

Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.

Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease.

Potential use of stem cells from bone marrow to repair the extracellular matrix and the central nervous system.

Anatomy of the brain neurogenic zones revisited: fractones and the fibroblast/macrophage network.

P304

e22924

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0022924

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51579484

http://www.w3.org/2001/XMLSchema#string

P698

21850243

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

3151281

http://www.w3.org/2001/XMLSchema#string